Translate
Protara Therapeutics, Inc.
About
4.92USD-0.05 -1.01%
Closed • Updated at 13:17 GMT+00:00Market Cap$276.52M
Volume1.13M
Beta0.52
RSI45.74
Protara Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 20 2026
Protara Therapeutics to Present at the TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA
May 18 2026
Protara Therapeutics to Host Virtual Investor Webinar to Discuss TARA-002 for Lymphatic Malformations on Tuesday, May 19, 2026
May 15 2026
Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses in the Fully Enrolled BCG-Naïve Cohort of the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in NMIBC
Apr 27 2026
Protara Therapeutics to Present Updated, Interim 12-Month Data from the Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Naïve NMIBC Patients at the American Urological Association Annual Meeting
Mar 10 2026
Protara Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
Recent Videos
This Tiny Biotech Could Change Diabetes Forever
May 06, 2026
Biotech is coming back around I JPM Healthcare Conference 2026
Mar 27, 2026
Cómo invertir en Protara Therapeutics Inc (TARA) paso a paso
Mar 11, 2026
How to Invest in Protara Therapeutics Inc (TARA) Step by Step
Mar 02, 2026
Community Chat
Ask AI
Try asking